What does the WHO say about obesity drugs for children under 10?
WHO warns against obesity drugs for children under 10, saying care should focus on healthy eating and exercise.
Covers: The WHO's official guidance, statements and reports on pharmacological treatment of obesity in children under 10, including when medication is considered appropriate and how it fits with diet, activity and family-based care. It does not cover individual treatment advice or drugs for adolescents and adults, except where guidance overlaps.
Also answers: WHO guidance on weight loss drugs for young children? · Does the WHO recommend obesity medication for kids under 10? · WHO position on pediatric obesity drugs? · Obesity drugs for children under 10 WHO advice
- One page for this question6 other ways of asking lead here
- 3 independent sourcesEvery claim links to what supports it
- 3 connected pages3 changed this week
- Clean discussionScreened before anything appears
The short answer
Evidence-backed AI-prepared starting mapThe World Health Organization's new global guidelines warn against using obesity drugs, including weight-loss injections, to treat children under 10. WHO says care for this age group should focus on healthy eating and exercise rather than medicines.1
- Evidence 11
- Interpretation 1
Did this answer your question?
Be the first to voteIn brief
WHO's new global guidelines warn against obesity drugs, including weight-loss injections, for children under 10.1
Evidence-backedWHO says care for under-10s should focus on healthy eating and exercise rather than medicines.1
Evidence-backedIn adolescents, lifestyle treatment alone produced substantial BMI reductions, and combining medication with lifestyle treatment gave the greatest short-term improvements.2
Evidence-backedChildhood obesity is usually diagnosed using BMI and is recognised as a serious public health concern, with prevalence differing by sex and gender.3
Evidence-backed
At a glance
What this page stands on
Live · updated just now
The evidence behind it
3 sources- Reviews of many studies1
- Background2
Published in 2026
| Source | Kind | Year |
|---|---|---|
| New global guidelines warn against obesity drugs for children under 10 | Background | 2026 |
| Obesity Management Pharmacotherapies and Lifestyle Treatment for Pediatric Obesity Management: A Systematic Review and Network Meta-Analysis. | Reviews of many studies | 2026 |
| Childhood obesity (Wikipedia) | Background | Unknown |
The community around it
No one has added to this page yet. Firsthand experience, a newer study or a different reading of the numbers would show up here, credited to you.
What it means for you
Which fits you?
Pick the situation closest to yours. Each answer says what it rests on.
If you are a parent or carer of a child under 10 with obesity
WHO's guidance points to healthy eating and exercise as the focus of care, and warns against obesity drugs including weight-loss injections for this age group.1
Evidence-backedIf you are looking at treatment evidence for an adolescent rather than a young child
the systematic review found lifestyle treatment alone gave substantial BMI reductions, and combining medication with lifestyle treatment gave the greatest short-term (typically 6 to 12 months) improvements — but these findings are for adolescents, not under-10s.2
Evidence-backedIf you want to understand how childhood obesity is defined and measured
diagnosis is usually based on BMI because measuring body fat directly is difficult, and the term "overweight" is often preferred over "obese" for children as it is less stigmatising.3
Evidence-backedThe full story · 2 chapters
01
What WHO says
AI summary:WHO's new guidelines advise against obesity drugs for under-10s, recommending healthy eating and exercise instead, and explain how childhood obesity is defined.
Evidence-backed: WHO's new global guidelines warn against obesity drugs for children under 10, including weight-loss injections such as those used in older age groups. The recommended focus for this age group is healthy eating and exercise rather than pharmacological treatment.1
Evidence-backed: Childhood obesity is defined as excess body fat negatively affecting a child's health or well-being; because measuring body fat directly is difficult, diagnosis is usually based on BMI. It is recognised as a serious public health concern, and prevalence is known to differ by sex and gender. The term "overweight" is often used instead of "obese" when discussing children, as it is considered less stigmatising.3
What is your view on using obesity drugs to treat children under 10?
Join free to voteAlready a member? Sign inYour individual answer is private. Only totals are shown.
02
What the treatment evidence shows — and for whom
AI summary:A review of adolescents found lifestyle treatment and medication together worked best, but results were short-term and not guidance for under-10s.
Evidence-backed: A systematic review and network meta-analysis found that all pharmacological treatments for pediatric obesity were more effective when paired with lifestyle treatment, producing significantly greater reductions in BMI and BMI z score than the same medications alone. Lifestyle treatment as monotherapy was itself associated with substantial decreases in BMI (mean difference -3.85; 95% CI -4.91 to -2.80) and BMI z score (mean difference -0.89; 95% CI -1.17 to -0.61) versus control. The authors concluded that lifestyle treatment remained an indispensable component of any effective weight management, and that combined with lifestyle treatment, pharmacotherapy was a key component rather than solely an adjunct.2
Interpretation: These findings concern adolescents with obesity, and the weight reductions observed were short-term, typically over 6 to 12 months. The review notes that long-term sustainability and safety were monitored, but the results should not be read as guidance for children under 10.2
Your turn
Have your say
See where others stand. Join free to add your perspective. One answer per account.
How do you feel about this?
No votes yetQuick questions from connected pages
Before you go
What to remember
Try to recall each hidden figure before you reveal it. Remembering, not rereading, is what makes it stick.
WHO's new global guidelines warn against obesity drugs, including weight-loss injections, for children under .
WHO says care for under-s should focus on healthy eating and exercise rather than medicines.
In adolescents, lifestyle treatment alone produced substantial BMI reductions, and combining medication with lifestyle treatment gave the greatest short-term improvements.
Your reading
0 of 2 chaptersThis answer keeps changing
When new evidence or a better source comes in, this page is updated (it's on version 2, last changed 1 hour ago). Follow it to be told when that happens.
Ask this Sylo
Still wondering about something?
Answers come only from this page's reviewed material, with citations, and say plainly when the page doesn't cover it yet.
Behind this page
Who's adding to it, where it comes from, how it changed and what would make it better. Always open to everyone.
Discussion
Sources
Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.
- 1New global guidelines warn against obesity drugs for children under 10BBC NewsPublished Oct 7, 2026Checked Oct 10, 2026
“Care should focus on healthy eating and exercise, not medicines such as weight-loss injections, says the World Health Organization”
- 2Obesity Management Pharmacotherapies and Lifestyle Treatment for Pediatric Obesity Management: A Systematic Review and Network Meta-Analysis.JAMA pediatrics (Wan et al.)Published Sep 1, 2026Checked Oct 10, 2026
“All pharmacological treatments were more effective when paired with lifestyle treatment, associated with significantly greater BMI and BMI z score reductions than the same medications alone. Based on the primary analysis, HBLT as monotherapy was associated with substantial decreases in BMI (mean difference, -3.85; 95% CI, -4.91 to -2.80) and BMI z score (mean difference, -0.89; 95% CI, -1.17 to -0.61) vs control.Conclusions and relevanceFinding of this systematic review and network meta-analysis suggest that combining lifestyle treatment with obesity management medications was associated with the greatest short-term (typically 6 to 12 months) weight reduction in adolescents with obesity. HBLT remained an indispensable component of any effective weight management, delivering meaningful weight loss and healthier body composition on its own. Combined with lifestyle treatment, pharmacotherapy was a key component, not solely an adjunct, associated with the greatest BMI and BMI z score improvements, and long-term sustainability and safety were monitored.”
- 3Childhood obesity (Wikipedia)WikipediaPublished Oct 6, 2026Checked Oct 10, 2026
“Childhood obesity is a condition where excess body fat negatively affects a child's health or well-being. As methods to determine body fat directly are difficult, the diagnosis of obesity is often based on BMI. Due to the rising prevalence of obesity in children and its many adverse health effects it is being recognized as a serious public health concern. The term overweight rather than obese is often used when discussing childhood obesity, as it is less stigmatizing, although the term overweight can also refer to a different BMI category. The prevalence of childhood obesity is known to differ by sex and gender.”
How it changed
Published 1 time since Oct 10, 2026.
- Version 2Oct 10, 2026Live now
AI-prepared Starting Map from live research.
- First published version.
Help improve it
The brief is open about what's uncertain. These are the specific gaps that new material would fill.
“What the treatment evidence shows — and for whom” rests on one independent source
A second, independent source that confirms or challenges it would make this part more reliable.
Open questions
What exactly do WHO's full guidelines recommend for children under 10, and under what circumstances, if any, would medication be considered?
No answers yet
How should evidence from adolescents be interpreted for younger children, given that the main systematic review covers adolescents rather than under-10s?
No answers yet
How do WHO's recommendations position family-based care, diet and activity alongside any clinical treatment for young children?
No answers yet
Around this topic
Sylos connect: narrower topics report up to broader ones, so what's learned in one place shows up where it matters.